Angiotensin 1-7 (Ang-(1-7)) is a major active component of the renin-angiotensin system (RAS), produced from cleavage of Ang II by angiotensin-converting-enzyme type 2 (ACE2). Angiotensin 1-7 inhibits purified canine ACE activity (IC50=0.65 μM). Angiotensin 1-7 acts as a local synergistic modulator of kinin-induced vasodilation by inhibiting ACE and releasing nitric oxide. Angiotensin 1-7 blocks Ang II-induced smooth muscle cell proliferation and hypertrophy and shows antiangiogenic and growth-inhibitory effects on the endothelium. Angiotensin 1-7 shows anti-inflammatory activity.
CAT No: R1805
CAS No:51833-78-4
Synonyms/Alias:Angiotensin (1-7);51833-78-4;angiotensin 1-7;ASP-ARG-VAL-TYR-ILE-HIS-PRO;TXA127;Angiotensin i (1-7);angiotensin-(1-7);Angiotensin II (1-7) heptapeptide;angiotensin II (1-7);8-Des-phe-angiotensin II;Ang-(1-7);TXA-127;Human angiotensin-(1-7);1-7-Human angiotensin II;Sh-heptapeptide-13;Bf-angiotensin 1-7;TXA 127;IJ3FUK8MOF;ang 1-7;MFCD00153513;39386-80-6;Angiotensin peptide (1-7);5-ile-angiotensin-(1-7);Human angiotensin ii (1-7);CHEBI:55438;Ile(5)-angiotensin II (1-7);Angiotensin II, 5-L-isoleucine-8-de-L-phenylalanine-;Angiotensin I/II (1-7) trifluoroacetate salt;(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid;Angiotensin (1-7) xTFA salt;L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-proline;L-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-proline;(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-hydroxy-4-oxobutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(3H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid;angiotensin-I (1-7);UNII-IJ3FUK8MOF;Angiotensin, Canine, Rat;Ang I (1-7);Angiotensin II, des-phe(8)-;(2S)-1-((2S)-2-(((2S,3S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-amino-4-hydroxy-4-oxobutanoyl)amino)-5-(diaminomethylideneamino)pentanoyl)amino)-3-methylbutanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)-3-methylpentanoyl)amino)-3-(3H-imidazol-4-yl)propanoyl)pyrrolidine-2-carboxylic acid;Ang-1-7 acetate;Angiotensin(1-7);DRVYIHP;Angiotensin II, des-phenylalanine(8)-;Angiotensin i/ii(1-7);Talfirastide (USAN/INN);GTPL582;Ang(1-7);GTPL5578;Therapeutic Angiotensin-(1-7);ANGIOTENSIN 1-7 ACETATE;CHEMBL3545347;SCHEMBL15926158;SCHEMBL25354851;BDBM85556;PVHLMTREZMEJCG-GDTLVBQBSA-N;[125I]ang-(1-7);GLXC-15146;ANGIOTENSIN 1-7 [WHO-DD];EX-A7295;SH-HEPTAPEPTIDE-13 [INCI];TXA127; Ang-(1-7);AKOS024456667;AKOS040759110;CS-3413;DB11720;Angiotensin (1-7) acetate salt hydrate;Angiotensin II, 8-de-L-phenylalanine-;NCGC00167219-01;AS-76407;DA-70861;FA108515;HY-12403;NS00073118;1-7-ANGIOTENSIN II, 5-L-ISOLEUCINE-;D12942;F85068;[125I]angiotensin-(1-7) (human, mouse, rat);BRD-K36040345-001-01-1;BRD-K36040345-001-02-9;Q27074464;(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-AMINO-3-CARBOXYPROPANAMIDO]-5-CARBAMIMIDAMIDOPENTANAMIDO]-3-METHYLBUTANAMIDO]-3-(4-HYDROXYPHENYL)PROPANAMIDO]-3-METHYLPENTANAMIDO]-3-(1H-IMIDAZOL-4-YL)PROPANOYL]PYRROLIDINE-2-CARBOXYLIC ACID;(S)-1-((6S,9S,12S,15S,18S)-18-((1H-imidazol-4-yl)methyl)-1-amino-6-((S)-2-amino-3-carboxypropanamido)-15-sec-butyl-12-(4-hydroxybenzyl)-1-imino-9-isopropyl-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazanonadecane)pyrrolidine-2-carboxylic acid;
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
4. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More